is tirzepatide coming off the market FDA Grants a New Indication for Obesity Management FDA says this weight loss

Serious side effects are rare but can occur, especially if you have one of the risk factors previously mentioned: Inflammation of the pancreas (pancreatitis) Gallbladder problems, including gallstones Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes Kidney problems Serious allergic reactions Changes in vision Increased heart rate while at rest Depression or thoughts of suicide If you have a severe allergic reaction, including swelling of your face, lips, tongue, or throat, trouble swallowing or breathing, severe rash or itching, gaining or feeling dizzy, or a very rapid heartbeat, discontinue treatment and call your health care provider immediately

And how many restart them?" The study found that the majority of people who discontinue GLP-1 medications eventually return to treatment

KK has received honoraria for lectures/advisory boards and research support from AstraZeneca, Boehringer Ingelheim, Pharmaserve Lilly, Sanofi-Aventis, ELPEN, MSD, and Novo Nordisk

The pen

Key difference: Side effect rates are roughly comparable between semaglutide and tirzepatide in clinical trials